GBM cell lines submitted to radiotherapy and subsequently confronted with PI-3 kinase and HSP90 inhibitors combined displayed increased cell death and decreased tumor growth in vivo, likely by disrupting AKT signaling, promoting G2/M arrest, and ultimately resulting in apoptosis [65]. This evidence concerns the gene HSP90AA1 and glioblastoma.